Home/Filings/4/0001209191-22-051047
4//SEC Filing

Kung Winston 4

Accession 0001209191-22-051047

CIK 0001817713other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 6:00 PM ET

Size

7.9 KB

Accession

0001209191-22-051047

Insider Transaction Report

Form 4
Period: 2022-09-21
Kung Winston
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-09-21+30,00030,000 total
    Exercise: $13.54Exp: 2032-09-20Common Stock (30,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-09-21+9,3759,375 total
    Exercise: $13.54Exp: 2032-09-20Common Stock (9,375 underlying)
Footnotes (2)
  • [F1]The shares subject to the option vest in equal monthly installments over a three year period following September 21, 2022 (the "Grant Date") such that the option is fully vested on the third anniversary of the Grant Date.
  • [F2]The shares subject to the option vest in equal monthly installments over a one year period following September 21, 2022 (the "Grant Date") such that the option is fully vested on the first anniversary of the Grant Date.

Issuer

Janux Therapeutics, Inc.

CIK 0001817713

Entity typeother

Related Parties

1
  • filerCIK 0001666963

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 6:00 PM ET
Size
7.9 KB